PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223425
PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223425
The Asia-Pacific knee cartilage market is projected to register a substantial CAGR of 11.1% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2023 to 2030.
Asia-Pacific Knee Cartilage Repair Market, By Product (Cell-Based & Non-Cell Based), Modality (Osteochondral Transplantation, Microfracture, Abrasion Arthroplasty, Drilling, Chondrocyte Implantation, and Others), Cartilage Type (Hyaline Cartilage, and Fibrocartilage), Application (Osteoarthritis, Rheumatoid Arthritis, Osteonecrosis, Fractures, Bone Tumors, and Others), End User (Hospital, Ambulatory Surgical Centers, Specialty Clinics, Research and Academic Institutes, and Others), Distribution Channel (Direct Sale, Third Party Distributor, Online Sales, and Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and Rest of Asia-Pacific) Industry Trends and Forecast to 2030.
Rise in the prevalence of knee disorders and knee surgeries
Increasing demand for minimally invasive procedures
Stryker
Zimmer Biomet
B. Braun Melsungen AG
Smith & Nephew
BioTissue
CONMED
DePuy Synthes Companies
Arthrex, Inc.
Medacta International
Regrow Biosciences Pvt. Ltd
Regentis Biomaterials Ltd.
Anika Therapeutics, Inc.
Auxein Medical
BioGend Therapeutics Co., Ltd.
CartiHeal, Inc. (A subsidiary of Bioventus Inc.)
MEDIPOST
Sartorius CellGenix GmbH
Sanofi
Waldemar Link GmbH & Co. KG
Geistlich Pharma AG